Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Curcuma longa showed no clear difference in adverse events Assessed clinically compared with placebo (moderate certainty).
STW5 (Iberogast) showed no clear difference in adverse events Assessed clinically compared with placebo (low certainty).
Peppermint/caraway oil showed no clear difference in adverse events Assessed clinically compared with placebo (low certainty).
RBD‐specific polyclonal F(ab') 2 fragments of equine antibodies… showed no clear difference in serious adverse events (by day 28) compared with saline placebo (low certainty).
It is very uncertain whether steroids changes adverse events: avascular necrosis compared with no specific treatment (very low certainty).
The review found no eligible studies for this question.
Hysterectomy (simple or radical) with neoadjuvant chemotherapy showed no clear difference in severe adverse events and toxicity compared with radiotherapy alone (low certainty).
Immediate treatment probably leads to higher adverse events (control ‐ placebo) compared with controls (moderate certainty).
It is very uncertain whether autologous blood or PRP changes withdrawal due to adverse events  compared with placebo at 3 months' follow‐up (very low certainty).
It is very uncertain whether hydromorphone changes specific adverse events – vomiting compared with morphine (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether hydromorphone changes specific adverse events – vomiting compared with oxycodone (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Steroid therapy in first episode of nephrotic syndrome: 3 months or… showed no clear difference in adverse events: Cushing's syndrome compared with 2 months of therapy (moderate certainty).
Pulse cyclophosphamide showed no clear difference in adverse events ‐ treatment failure compared with continuous cyclophosphamide (low certainty).
Calcineurin inhibitor showed no clear difference in adverse events: serious infections compared with IV cyclophosphamide (moderate certainty).
Oral cyclophosphamide showed no clear difference in adverse events: death (all causes) compared with prednisone or placebo (low certainty).